Literature DB >> 28738114

I-SPY 2 Breast Cancer Trial as a Model for Innovation in Alzheimer Disease Therapies.

Mindi F Messmer1,2, Erin E Wilhelm1,3, Ira Shoulson1,3.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28738114     DOI: 10.1001/jamaneurol.2017.1528

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  4 in total

Review 1.  Innovative Approaches for Slowing Disease Progression in Parkinson's Disease: Takeaways from the 14th Annual International Society for Central Nervous System Clinical Trials and Methodology Scientific Meeting.

Authors:  Monica Javidnia; Mark Frasier; Ira Shoulson; Ibrahim Turkoz; Kumar Budur
Journal:  Innov Clin Neurosci       Date:  2020-01-01

Review 2.  Disease modification and biomarker development in Parkinson disease: Revision or reconstruction?

Authors:  Alberto J Espay; Lorraine V Kalia; Ziv Gan-Or; Caroline H Williams-Gray; Philippe L Bedard; Steven M Rowe; Francesca Morgante; Alfonso Fasano; Benjamin Stecher; Marcelo A Kauffman; Matthew J Farrer; Chris S Coffey; Michael A Schwarzschild; Todd Sherer; Ronald B Postuma; Antonio P Strafella; Andrew B Singleton; Roger A Barker; Karl Kieburtz; C Warren Olanow; Andres Lozano; Jeffrey H Kordower; Jesse M Cedarbaum; Patrik Brundin; David G Standaert; Anthony E Lang
Journal:  Neurology       Date:  2020-02-26       Impact factor: 9.910

3.  I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer.

Authors:  Haiyun Wang; Douglas Yee
Journal:  Curr Breast Cancer Rep       Date:  2019-11-20

Review 4.  Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options.

Authors:  Jeffrey L Cummings; Gary Tong; Clive Ballard
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.